Picture of DarioHealth logo

DRIO — DarioHealth News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

DarioHealth Corp expected to post a loss of 27 cents a share - Earnings Preview

* DarioHealth Corp  DRIO.OQ   DRIO.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 7 for
the period ending September 30 2024
    * The New York City-based  company is expected to report a
110.3% increase in revenue to $7.397 million from $3.52 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for DarioHealth Corp is for
a loss
of 27 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for DarioHealth
Corp
is 3.50​, above​ its last closing price of $0.89. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.55       -0.55      -0.08     Beat    85.6
 Jan. 1 2024   -0.48       -0.40      -0.20     Beat    50.6
 Dec. 31 2023  -0.54       -0.55      -0.50     Beat    9.6​
 Sep. 30 2023  -0.48       -0.46      -0.49     Missed  -6.5
 ​​Jan.        -0.57       -0.52      -0.58     Missed  -11.1
 1 0001                                                 
 Jan. 1 0001   -0.49       -0.50      -0.45     Beat    9.6​
 Dec. 31 2022  -0.56       -0.65      -0.51     Beat    21.8
 Sep. 30 2022  -0.71       -0.76      -0.64     Beat    16.1
 This summary was machine generated November 6 at 14:27 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on DarioHealth

See all news